William J Burnett

ASA Suppresses PGE2 in Plasma and Melanocytic Nevi of Human Subjects at Increased Risk for Melanoma

S. Florell, M. VanBrocklin, D. Grossman, 2020, Pharmaceuticals.

AKT1 Activation Promotes Development of Melanoma Metastases.

M. McMahon, S. Holmen, M. VanBrocklin, 2015, Cell reports.

AKT 1 Activation Promotes Development of MelanomaMetastases

M. McMahon, S. Holmen, M. VanBrocklin, 2015 .

Genetic silencing of AKT induces melanoma cell death

M. McMahon, S. Holmen, M. VanBrocklin, 2022, bioRxiv.

Prior Exposure to Coxsackievirus A21 Does Not Mitigate Oncolytic Therapeutic Efficacy

S. Holmen, M. VanBrocklin, Matthew A. Williams, 2021, Cancers.

Human Rhinoviruses: a novel class of oncolytic virus

S. Holmen, M. VanBrocklin, Matthew A. Williams, 2023, bioRxiv.

A phase I open-label study of the safety and efficacy of apatinib (rivoceranib) administered to patients with advanced malignancies to improve sensitivity to pembrolizumab in the second- or later-line setting (APPEASE)

K. Boucher, J. Whisenant, J. Hawks, 2023, BMC Research Notes.